CHIMERIC ANTIBODIES FOR TREATMENT OF AMYLOID DEPOSITION DISEASES

A chimeric mouse-human antibody for treatment of amyloid deposition diseases, pharmaceutical compositions comprising the antibody, methods and materials for producing the antibody, and methods for treating an amyloid deposition disease using the antibody and the pharmaceutical composition.

Saved in:
Bibliographic Details
Main Authors Jones, Tarran, O'Brien, Siobhan, Levy, Alison
Format Patent
LanguageEnglish
Published 11.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A chimeric mouse-human antibody for treatment of amyloid deposition diseases, pharmaceutical compositions comprising the antibody, methods and materials for producing the antibody, and methods for treating an amyloid deposition disease using the antibody and the pharmaceutical composition.
AbstractList A chimeric mouse-human antibody for treatment of amyloid deposition diseases, pharmaceutical compositions comprising the antibody, methods and materials for producing the antibody, and methods for treating an amyloid deposition disease using the antibody and the pharmaceutical composition.
Author Jones, Tarran
Levy, Alison
O'Brien, Siobhan
Author_xml – fullname: Jones, Tarran
– fullname: O'Brien, Siobhan
– fullname: Levy, Alison
BookMark eNrjYmDJy89L5WRwcPbw9HUN8nRWcPQL8XTyd_F0DVZw8w9SCAlydQzxdfULUfB3U3D0jfTx93RRcHEN8A_2DPH091Nw8Qx2dQx2DeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRgaGFoZGJmaOhsbEqQIAdtstYQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2020181246A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2020181246A13
IEDL.DBID EVB
IngestDate Fri Aug 02 08:54:32 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2020181246A13
Notes Application Number: US201816626613
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200611&DB=EPODOC&CC=US&NR=2020181246A1
ParticipantIDs epo_espacenet_US2020181246A1
PublicationCentury 2000
PublicationDate 20200611
PublicationDateYYYYMMDD 2020-06-11
PublicationDate_xml – month: 06
  year: 2020
  text: 20200611
  day: 11
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies The Trustees of Columbia University in the City of New York
RelatedCompanies_xml – name: The Trustees of Columbia University in the City of New York
Score 3.2667596
Snippet A chimeric mouse-human antibody for treatment of amyloid deposition diseases, pharmaceutical compositions comprising the antibody, methods and materials for...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title CHIMERIC ANTIBODIES FOR TREATMENT OF AMYLOID DEPOSITION DISEASES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200611&DB=EPODOC&locale=&CC=US&NR=2020181246A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-LHlICyW7GbXbYdirZNyyq2HWsr8zSWNgVBuuEq_vu-hE532i3Jg_AS-OXll7wPgHs-oAskFromMm5oaPF6Gu_SniYMWlA9z_qFqjwXhHScGi-z_qwBn5tYGJUn9EclR0REZYj3Sp3Xq_9HLKZ8K9cP_AOHlk9eYrJOzY4lP0bsMtt0JxGLnI7jmGncCadKpowZtZAr7eFFeiAdwNw3W8alrLaNincM-xOcr6xOoCHKFhw6m9prLTgI6i9vbNboW5_CszP2VZFGYoWJb0fyKkeQxZFk6lqJzMpPIo9Ywftr5DPCULnYly9QhPmxa-HBeQZ3nps4Yw1Vmf-tfJ7G23o_nkOzXJbiAkihj4p8qGe5wblhLPp8RDMxFPlglAk65OIS2rtmutotvoYj2ZUeUd1uG5rV17e4Qdtb8Vu1Zb-VgYIK
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQFlb8Vudln3MLRrWlpd27F2Mp_G0qYgSDdcxX_fS9h0T3sLOTgugfv4XXJ3APe8S-cILHRNpNzQ0OO1Nd6ibU0YNKd6lnZyNXkuCKk3MV6mnWkFPje1MKpP6I9qjogalaK-l8peL_-TWEz9rVw98A_cWjy5SZ811-hY4mPUXTboO6OIRXbTtvuTuBmOFU05M2ohVtrDINuUnfadt4GsS1luOxX3CPZHyK8oj6EiijrU7M3stTocBOsnb1yutW91As-256shjcQKE38QyVCOIIojydixEtmVn0QusYL3YeQzwlC42JcZKML82LHQcJ7CnesktqehKLO_k88m8bbcj2dQLRaFOAeS6708M_U0Mzg3jHmH92gqTJF1e6mgJhcX0NjF6XI3-RZqXhIMZ0M_fL2CQ0mSv6NarQZUy69vcY1-uOQ36vp-AdcLhPo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CHIMERIC+ANTIBODIES+FOR+TREATMENT+OF+AMYLOID+DEPOSITION+DISEASES&rft.inventor=Jones%2C+Tarran&rft.inventor=O%27Brien%2C+Siobhan&rft.inventor=Levy%2C+Alison&rft.date=2020-06-11&rft.externalDBID=A1&rft.externalDocID=US2020181246A1